THCNYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31

TENET HEALTHCARE CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026

$266.39−0.86 (-0.32%)

Close on Oct 19, 2026

Market cap: $22.37B
P/E (TTM): 10.3
Dividend yield: –

TENET HEALTHCARE CORP cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31
Depreciation & Amortization	863	818	870	841	855	857	850	802	870	850	797	849	545	430	398	380	386	371
Stock-Based Compensation	104	67	66	56	56	44	42	46	59	68	69	51	36	32	24	22	23	33
Deferred Income Taxes	9.00	-103	52	209	250	-128	144	147	200	41	42	30	-67	92	81	-952	20	-14
Other Non-Cash Items	6.00	4.00	4.00	-11	10	4.00	15	21	18	1.00	-59	30	20	12	13	5.00	-6.00	–
Change in Accounts Receivable	20	245	-29	-140	-197	195	-247	-134	-1,448	-1,604	-1,632	-1,896	-987	-868	-850	-731	-645	-647
Change in Accounts Payable	209	-30	215	-898	-584	1,302	12	-142	-10	-51	68	505	38	9.00	-32	-87	12	-29
Operating Cash Flow	3,540	2,047	2,374	1,083	1,568	3,407	1,233	1,049	1,200	558	1,026	687	589	593	497	472	425	208
Capital Expenditures	-1,010	-931	-751	-762	-658	-540	-670	-617	-707	-875	-842	-933	-691	-506	-467	–	–	–
Acquisitions	-308	-571	-224	-234	-1,220	-1,177	-25	-113	-50	-117	-940	-428	-1,515	-211	-84	-65	0	-92
Divestitures	38	4,981	71	210	1,248	77	63	543	827	573	549	6.00	20	45	0	19	221	160
Purchase of Investments	-90	-94	-104	-92	-108	-44	-62	-148	-81	–	–	–	–	–	0	0	-17	-26
Sale & Maturity of Investments	–	–	50	76	31	–	–	–	–	–	–	–	–	–	0	0	49	8.00
Other Investing Activities	2.00	-19	-11	-6.00	-7.00	17	-24	6.00	6.00	-3.00	-6.00	1.00	3.00	4.00	-1.00	3.00	-1.00	2.00
Investing Cash Flow	-1,275	3,429	-969	-808	-714	-1,608	-619	-115	21	-430	-1,317	-1,322	-2,164	-662	-503	-420	-125	-274
Share Repurchases	-1,386	-672	-200	-250	0	0	–	–	0	0	-40	–	-400	-126	-374	0	0	–
Debt Issued	2,276	23	1,370	2,023	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Debt Repaid	-2,372	-2,243	-1,542	-2,851	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Taxes Paid on Share-Based Awards	-51	-25	-12	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Other Financing Activities	55	58	83	-46	-64	33	16	54	29	16	37	21	5.00	6.00	3.00	7.00	8.00	8.00
Financing Cash Flow	-2,401	-3,685	-1,035	-1,781	-936	385	-763	-1,134	-1,326	232	454	715	1,324	320	-286	-337	-117	1.00
Net Change in Cash	-136	1,791	370	-1,506	-82	2,184	-149	-200	-105	360	163	80	-251	251	-292	-285	183	-65
Free Cash Flow	2,530	1,116	1,623	321	910	2,867	563	432	493	-317	184	-246	-102	87	30	–	–	–
Income Taxes Paid	450	1,271	243	161	92	12	12	25	56	33	7.00	8.00	-6.00	-13	-10	34	-43	-4.00
Interest Paid	865	851	882	848	937	962	946	976	939	932	859	726	426	376	-347	-402	-439	391

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: 20.8%
Net margin: –
Return on equity, FY2025: –

Financial strength

Current ratio: 1.41
Debt to equity: 2.84
Debt to assets: 43.2%
Cash to current liabilities: 39.0%

Valuation

P/E ratio: 10.3
Price to sales: 1.03
Price to book: 4.80
Dividend yield: –